multimodal physical therapy for vulvodynia
A state-of-the-science review reports multimodal physical therapy has among the highest levels of evidence for vulvodynia, supported by at least one RCT and pre-post reductions in vulvar pain and dyspareunia in non-RCT studies.
Hypothesized mechanism
Mechanism not yet characterized in the substrate.
This is the model’s proposed mechanism from the sources on file, not a demonstrated causal pathway. How well the published record supports it is reflected in the rigor and plausibility dimensions of the score, and traced to the verbatim sources at the foot of the page.
How the score was reached, for this pair
The composite score is the sum of five dimensions, each scored 0 to 2 by the model from the evidence on file. Below is the sub-score this specific pair received on each, with what that dimension measures. It scored 7 of 10 overall, a moderate reading, from a direct rated moderate in strength.
The model’s overall reasoning for this pair is the summary at the top of the page, and the mechanism it proposed is in the section above.
Scored for women. Evidence generated in women (female population). (band F1, ×1.00).
Corroboration
Evidence comes from a single review source ('State of the Science') summarizing the literature, not independent replication. It cites at least one RCT plus non-RCT pre-post studies, but all are reported via one synthesis, capping corroboration at 1.
Rigor
Claim 1 states multimodal physical therapy had the highest level of evidence 'with at least one RCT or comparative effectiveness trial,' indicating RCT-level design. The supporting source is a state-of-the-science review, both consistent with a rigor score of 2.
Specificity
Both the intervention (multimodal physical therapy) and the condition (vulvodynia) are named directly in the claims and quotes. The source title explicitly concerns vulvodynia.
Plausibility
The claims report symptom reduction in vulvar pain and dyspareunia but do not articulate or evidence a specific mechanism for physical therapy. Pelvic physical therapy has a plausible mechanism (addressing pelvic floor dysfunction), but no mechanistic detail is provided here.
Consistency
Both claims point in a favorable direction (highest evidence level plus pre-post pain reduction), but they derive from a single review rather than multiple independent datasets. Direction is consistent but not independently replicated, so a neutral score applies.
Layers not covered for this pair
Not covered for this pair. This layer holds documented sex-specific pharmacokinetics for a limited set of drugs, and this compound is not among them yet. A blank here means the drug is not covered by the layer, not that no sex difference exists.
More on the sex-specific pharmacokinetics layer and its sources →Not covered for this pair. The cycle-phase layer is seeded for the strongest-evidence cases so far (PMDD), and this pair is not among them yet. A blank here means the pair is not covered by the layer, not that the effect was found to be phase-independent.
More on the cycle-phase layer and its sources →Source evidence · what the pipeline ingested
These are the sources the pipeline ingested to detect and score this signal, the published literature the model actually read, each tagged by study type. Where the model combined findings the claim is marked as a synthesis (S), and where the literature disagrees the contradiction is shown (!).
Every source below belongs to this signal’s evidence arm, Direct research. Whel reads each drug-condition pair through four such arms, each held to its own inclusion bar; a signal is surfaced through one of them.
- 1multimodal physical therapy, overnight 5% lidocaine ointment, and acupuncture had the highest level of evidence with at least one RCT or comparative effectiveness trial. PubMed · PMID 36533637 ↗
- 2Pre to posttest reduction in vulvar pain and/or dyspareunia in non-RCT studies included studies of gabapentin cream, amitriptyline cream, amitriptyline with baclofen cream, up to 6 weeks' oral itraconazole therapy, multimodal physical therapy PubMed · PMID 36533637 ↗
These are the verbatim sources the pipeline surfaced and read; they may not be the full published record for a pair, and the score reflects the strength and agreement of the evidence rather than its volume. The strength of these source types is what the rigor dimension of the score reads off. MATRIX, sex-specific pharmacokinetics, and cycle phase are separate layers the pipeline does not ingest, external cross-references reported beside the score, and they link to their own sources in their sections above.
The primary sources and pipelines this evidence is drawn from →